Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), ...

Eli Lilly and Co (NYSE:LLY) has entered into a drug discovery collaboration with Insilico Medicine, a clinical-stage ...

U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its ...

Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase of nearly ...

The FDA has approved a high-dose regimen of Biogen’s nusinersen (SPINRAZA) for the treatment of spinal muscular atrophy. 1 ...

March 29 (Reuters) - Generative-AI drug developer Insilico Medicine said on Sunday it has agreed a global licensing and ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

BullFrog AI Holdings, Inc. (NASDAQ:BFRG), a technology company focused on applying artificial intelligence and machine ...

Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for ...

In today's Pharmaceutical Executive Daily, Eli Lilly presses the U.K. government to overhaul its NHS drug pricing framework ...